Table 1.
Frequencies of drugs involved in incompatible drug combinations in an incompatibility analysis in an interdisciplinary critical care unit (n = 130 drug combinations)
| Drug | Frequency [n] | Percent [%] |
|---|---|---|
| Furosemide | 18 | 13.8 |
| Pantoprazole | 18 | 13.8 |
| Piperacillin/tazobactam | 17 | 13.1 |
| Heparin | 16 | 12.3 |
| Erythromycin | 16 | 12.3 |
| Cefuroxime | 11 | 8.4 |
| Ringer’s acetate | 11 | 8.4 |
| Ampicillin/sulbactam | 10 | 7.7 |
| Metoclopramide | 9 | 6.9 |
| Caspofungin | 8 | 6.2 |
| Dipyrone | 8 | 6.2 |
| Levetiracetam | 7 | 5.4 |
| Prednisolone | 6 | 4.6 |
| Magnesium sulfate | 6 | 4.6 |
| Metronidazole | 6 | 4.6 |
| Meropenem | 6 | 4.6 |
| Ciprofloxacin | 6 | 4.6 |
| Amiodarone | 6 | 4.6 |
| Linezolid | 5 | 3.8 |
| Calcium chloride | 5 | 3.8 |